SMPD3 and chronic obstructive pulmonary disease: Neutral sphingomyelinase-2 (nSMase-2), which hydrolyzes sphingomyelin to produce ceramide, is elevated in small airways cells and alveolar macrophages from COPD patients compared with the control [64].